Ocugen
Jan 09, 2023
Malvern, Pa.: A biopharmaceutical company focused on discovering, developing, and commercialising novel gene and cell therapies and vaccines, today announced positive results from the Phase 2/3,...
© Copyright Sakshi Post 2025 All rights reserved.
Powered by Yodasoft Technologies Pvt Ltd